American Express Co. buy BiotechBee
Start price
17.09.23
/
70%
€153.05
Target price
31.01.26
€200.00
Performance (%)
3.92%
End price
02.12.23
€159.05
Summary
This prediction ended on 02.12.23 with a price of €159.05. With a performance of 3.92%, the BUY prediction by BiotechBee for American Express Co. closed with a slight gain. A total of €0.57 was paid as dividends for this prediction. BiotechBee has 70% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y |
|---|---|---|---|
| American Express Co. | -2.842% | -2.842% | 2.454% |
| iShares Core DAX® | -2.117% | -7.974% | -1.733% |
| iShares Nasdaq 100 | -1.323% | -0.066% | 16.602% |
| iShares Nikkei 225® | -0.324% | -6.382% | 25.629% |
| iShares S&P 500 | -1.568% | -1.965% | 10.831% |
According to BiotechBee what are the pros and cons of American Express Co. for the foreseeable future?
Pros
Could be very worthwhile Investment >20% year
Cons
Comments by BiotechBee for this prediction
In the thread American Express Co. diskutieren
Buy mit Kursziel 200,0